je.st
news
GSK's breast cancer drug Tykerb fails in gastric cancer study
2013-06-03 14:37:51| Biotech - Topix.net
GlaxoSmithKline said on Monday that its breast cancer drug lapatinib in combination with chemotherapy did not improve survival rates for patients with gastric cancer compared to the use of chemotherapy alone.
Tags: study
drug
cancer
fails
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||